Granted Patent
B2
US 7,645,456 · App. 10/826,680 · Granted Jan 12, 2010
Vaccinia virus strains
Assignee:
Sanofi Pasteur Biologics Co.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
Claims (2)
1. A pharmaceutical composition comprising an isolated clonal strain of attenuated vaccinia virus, wherein the isolated clonal strain of attenuated vaccinia virus is ACAM1000 (ATCC Deposit No. PTA-3321).
2. A pharmaceutical composition comprising an isolated clonal strain of attenuated vaccinia virus that is obtained from cell cultures in which ACAM1000 (ATCC Deposit No. PTA-3321) has been propagated.
Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 044191 FRAME: 00034. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT .
Recorded Jan 2, 2018
From: SANOFI PASTEUR BIOLOGICS, LLC; ACAMBIS RESEARCH LTD.
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 044976/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 21, 2017
From: SANOFI PASTEUR BIOLOGICS, LLC; ACAMBIS RESEARCH LTD.
To: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Reel/Frame 044191/0034 →
CHANGE OF NAME
Recorded Oct 18, 2016
From: SANOFI PASTEUR BIOLOGICS CO.
To: SANOFI PASTEUR BIOLOGICS, LLC
Reel/Frame 040396/0288 →
CHANGE OF NAME
Recorded Jul 10, 2009
From: ACAMBIS INC.
To: SANOFI PASTEUR BIOLOGICS CO.
Reel/Frame 022938/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 30, 2004
From: WELTZIN, RICHARD A.; MONATH, THOMAS P.
To: ACAMBIS, INC.
Reel/Frame 015206/0063 →
Continuity (3)